OraSure Technologies, Inc. and Leaders in HIV Prevention Open the NASDAQ Stock Market; Company Recognizes National HIV Testing Day
New Jersey Mandates Certification of Central Service Professionals
IQ Corporations Anthrax Products Selected for Testing by CDC
Defeat Bioterrorism With More International Collaboration, Experts Say
The Search for a Safer Smallpox Vaccine Reveals New Data on a Promising Candidate
Surveillance Study Shows KETEK Tablets to be 99 Percent Effective in Vitro Against Streptococcus Pneumoniae Bacteria
Study Tests Potential Herpes Vaccine
Russian Researcher Dies After Contact With Ebola Virus
FailSafe Air Safety Systems Corp Launches Portable Isolation Containment System for Bioterrorism Response and Infectious Disease Control
Regeneration Technologies Announces That Sterilized Soft Tissue Allografts Through Biocleanse are Now Available
Company's Technology Demonstrates Ability to Detect CJD in Human Blood
National Time Out Day Celebrates Adoption of First Universal Protocol to Prevent Errors in U.S. Operating Rooms
Researchers Report That SARS Has Been Found in Tears
Analysis Shows Infants of Mothers Infected With HIV Face Nearly Constant Risk For HIV Infection For Duration of Breastfeeding
SurgiLance Awarded Three-Year Contract by UK's NHSpasa
Researchers Discover Infiltration of the Brain by Pathogens May Cause Alzheimer's Disease
Surgical Morbidity and Mortality Should Decrease With New Infection Prevention Guidelines, Says Industry Workgroup
One in Three HIV-Positive Gay Men are Unaware They Are Infected
Diagnostic Strategies Detect HIV Earlier and More Effectively Than Ever
Researchers Find That Myth of Disease Threat Posed by Dead Bodies After Natural Disasters is Unfounded
Europe is Successful in Fight Against Foot-and-Mouth Disease but Risks Remain
Peninsula Pharmaceuticals, Inc. Begins Phase III Clinical Trial of Doripenem for the Treatment of Hospital-Acquired Pneumonia
'Gate-Keeper' Patent Granted for Novel Germicidal Device to Help Prevent Hospital-Acquired Infections
NIH Supports Phase 1 Clinical Trial of Vical's DNA-Based Anthrax Vaccine
Make a Splash for Public Health This Summer
Top Scientists Present Progress on Vaccines for SARS, Pandemic Influenza and Other Lethal Infectious Diseases
Procter & Gamble and CDC Collaboration Results in Landmark Public Health Contribution
New Study Challenges Current Thinking About Varied Response to Hepatitis C Treatment in Different Racial Groups
Chiron to Produce Avian Influenza Vaccine for National Institutes of Health Studies
Study Shows Herpes is Common in Suburban Populations
